Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 4,270 | 1,932 | 1,629 | 437 | 124 |
| Income taxes - deferred | 913 | 1,850 | 2,058 | 723 | 910 |
| Accounts receivable | -10,319 | -2,609 | 690 | -7,898 | -2,201 |
| Accounts payable and accrued liabilities | 10,680 | 1,075 | 1,818 | 1,943 | 326 |
| Other Working Capital | -12,199 | -23,338 | 3,050 | -3,462 | -3,818 |
| Other Operating Activity | 11,251 | 15,351 | 14,212 | 22,995 | 12,295 |
| Operating Cash Flow | $4,596 | $-5,739 | $23,457 | $14,738 | $7,636 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -109 | -202 | -126 | -7 | 0 |
| Net Acquisitions | -172,306 | N/A | 0 | 2,157 | -217 |
| Purchase Of Investment | -247,667 | -586,489 | -338,611 | -568,559 | -610,279 |
| Sale Of Investment | 422,567 | 302,310 | 280,022 | 558,994 | 543,007 |
| Purchase Sale Intangibles | -2,839 | -3,670 | 0 | -9,853 | -1,750 |
| Other Investing Activity | -11,506 | 35,737 | 18,723 | -31,950 | 2,155 |
| Investing Cash Flow | $-11,860 | $-252,314 | $-39,992 | $-49,218 | $-67,084 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8,612 | N/A | N/A | N/A | 0 |
| Common Stock Issued | N/A | N/A | 0 | 313,679 | 12,501 |
| Common Stock Repurchased | -54,838 | N/A | 0 | -350 | 0 |
| Other Financing Activity | 655 | 290 | 746 | 0 | 1,361 |
| Financing Cash Flow | $-62,795 | $290 | $746 | $313,329 | $13,862 |
| Exchange Rate Effect | -458 | 6,088 | -2,693 | -1,388 | -378 |
| Beginning Cash Position | 244,785 | 496,460 | 514,942 | 237,481 | 283,445 |
| End Cash Position | 174,268 | 244,785 | 496,460 | 514,942 | 237,481 |
| Net Cash Flow | $-70,059 | $-257,763 | $-15,789 | $278,849 | $-45,586 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,596 | -5,739 | 23,457 | 14,738 | 7,636 |
| Capital Expenditure | -2,948 | -3,872 | -126 | -9,860 | -1,750 |
| Free Cash Flow | 1,648 | -9,611 | 23,331 | 4,878 | 5,886 |